asthma - Nursing Case Study
Pathophysiology
• Primary mechanism: Airway inflammation - In asthma, the airways become inflamed due to an exaggerated immune response to allergens or irritants. This inflammation leads to swelling and increased mucus production, narrowing the airways and causing difficulty in breathing.
• Secondary mechanism: Bronchoconstriction - The muscles surrounding the airways tighten excessively in response to triggers, further narrowing the airways. This bronchoconstriction results in wheezing, coughing, and shortness of breath.
• Key complication: Airway hyperresponsiveness - Chronic inflammation and repeated exposure to triggers make the airways more sensitive, leading to frequent and severe asthma attacks. This ongoing cycle can cause airway remodeling and a decline in lung function over time.
Patient Profile
Demographics:
45-year-old female, office administrator
History:
• Key past medical history: Asthma diagnosed at age 30, seasonal allergies, hypertension
• Current medications: Fluticasone/Salmeterol inhaler, Albuterol as needed, Lisinopril
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Increased shortness of breath and wheezing
• Key symptoms: Persistent cough, chest tightness, and fatigue
• Vital signs: Blood pressure 145/90 mmHg, heart rate 102 bpm, respiratory rate 24 breaths per minute, temperature 98.6°F, oxygen saturation 92% on room air
Section 1
Following the initial assessment, the patient's condition was closely monitored, and spirometry was performed to evaluate lung function. The results revealed a significant reduction in FEV1 (Forced Expiratory Volume in 1 second), measuring at 60% of the predicted value, indicating moderate obstruction. Additionally, the peak expiratory flow rate was 230 L/min, further confirming the compromised airway function. These findings suggest that the patient's asthma is not well-controlled, and the presence of airway hyperresponsiveness is contributing to the worsening symptoms.
In light of the increased shortness of breath and persistent cough, a chest X-ray was ordered to rule out any underlying infections or complications such as pneumonia. The X-ray indicated mild hyperinflation of the lungs, which is consistent with asthma exacerbation, but no signs of infection were noted. Blood tests showed elevated eosinophil levels, supporting the diagnosis of an ongoing allergic response exacerbating the patient's asthma. These diagnostic results highlight the need for a reassessment of the patient's current asthma management plan, considering potential adjustments to her medication regimen to better control her symptoms and prevent further deterioration.
Based on these findings, the healthcare team is considering stepping up the patient's treatment plan. This may involve increasing the dose of her inhaled corticosteroid or adding a leukotriene receptor antagonist to address the airway inflammation more effectively. The patient's response to a short-acting bronchodilator is also being evaluated to determine the efficacy of her current rescue medication. The goal is to achieve better control over her asthma, reduce the frequency of exacerbations, and prevent any potential long-term complications such as irreversible airway remodeling. The next steps will focus on optimizing her treatment strategy and monitoring her response to these interventions.
Section 2
Following the adjustment to her asthma management plan, which included an increase in the dose of her inhaled corticosteroid and the addition of a leukotriene receptor antagonist, the patient initially reported a slight improvement in her symptoms. However, two days later, she returned to the clinic with worsening dyspnea and increased nocturnal awakenings due to coughing fits. During this visit, her vital signs revealed a respiratory rate of 28 breaths per minute, heart rate of 110 beats per minute, and oxygen saturation of 92% on room air, indicative of respiratory distress. Auscultation of the lungs noted diffuse wheezing and diminished breath sounds in both lower lobes.
Given these concerning changes, the healthcare team ordered a repeat spirometry test, which showed a further decrease in FEV1 to 55% of the predicted value. Additionally, arterial blood gas analysis revealed mild respiratory acidosis with a pH of 7.32, PaCO2 of 48 mmHg, and PaO2 of 68 mmHg. These findings suggest that despite the recent modifications to her treatment regimen, the patient is experiencing a significant exacerbation of her asthma, potentially leading to respiratory failure if not promptly managed.
In light of these developments, the healthcare team is considering the initiation of systemic corticosteroids to rapidly reduce airway inflammation and alleviate the acute exacerbation. The patient’s response to nebulized bronchodilator therapy will also be closely monitored during her stay in the emergency department. The team will reassess the need for hospitalization and possible escalation to non-invasive ventilation should her respiratory status continue to deteriorate. These steps are crucial to prevent further complications and stabilize the patient's condition.
Section 3
Response to Interventions:
Following the administration of systemic corticosteroids, the patient was closely monitored for improvements in her respiratory status. Over the next several hours, she received nebulized bronchodilator therapy every 20 minutes, aimed at alleviating her bronchospasm. Initial observations indicated a slight reduction in her respiratory rate to 26 breaths per minute and a decrease in heart rate to 102 beats per minute. Her oxygen saturation showed marginal improvement, rising to 94% on supplemental oxygen delivered at 2 liters per minute via nasal cannula. However, despite these interventions, the patient continued to experience significant dyspnea and required ongoing reassessment.
A repeat arterial blood gas analysis conducted two hours post-intervention revealed a pH of 7.34, PaCO2 of 46 mmHg, and PaO2 of 72 mmHg, reflecting a slight improvement in her acid-base status, yet still suggestive of ongoing respiratory compromise. Auscultation of the lungs continued to show diffuse wheezing with intermittent crackles in the lower lobes, raising concerns of potential mucus plugging or early atelectasis. The healthcare team deliberated on further escalation strategies, including the potential initiation of continuous positive airway pressure (CPAP) to provide additional support for her respiratory mechanics and facilitate better alveolar ventilation.
As the patient remained in the emergency department, the medical team emphasized the importance of continuous monitoring and reevaluation of her treatment plan. Her response to corticosteroids and bronchodilators would determine the next steps, including the necessity for hospital admission and further diagnostic testing, such as chest X-rays or a CT scan, to rule out additional complications like pneumonia or pneumothorax. The interprofessional team, including respiratory therapists, nurses, and physicians, collaborated to ensure a comprehensive approach to the patient's care, keeping a vigilant eye on any changes that might necessitate further intervention.
Section 4
As the patient continued to be monitored in the emergency department, her clinical status began to show signs of further complications. Approximately four hours after the initial interventions, her respiratory distress seemed to worsen, with an increase in respiratory rate to 30 breaths per minute and complaints of chest tightness. Her oxygen saturation, despite being on 2 liters per minute of supplemental oxygen, decreased to 91%. The patient appeared increasingly anxious and fatigued, indicating a potential progression of her respiratory compromise.
In light of these changes, a chest X-ray was expedited to investigate further. The imaging revealed atelectasis in the right lower lobe, likely due to mucus plugging, and a modest amount of peribronchial thickening, which can be indicative of ongoing inflammation or early infectious processes. Given these findings, the healthcare team decided to escalate her care by initiating a trial of continuous positive airway pressure (CPAP) to help recruit collapsed alveoli and improve her ventilation.
The decision to start CPAP was supported by her lab results and clinical presentation. Repeat arterial blood gas analysis, taken shortly before the CPAP initiation, showed a pH of 7.32, PaCO2 of 48 mmHg, and PaO2 of 68 mmHg, indicating worsening hypercapnia and hypoxemia. The interprofessional team, including the respiratory therapist, worked to adjust the CPAP settings to optimize her breathing while closely monitoring her response. This escalation in care was necessary to prevent further deterioration and to stabilize her condition, with plans to reassess her need for potential transfer to a higher level of care or admission to a respiratory unit.
Section 5
As the CPAP therapy was initiated, the patient's immediate response was closely monitored. Over the next hour, her respiratory rate gradually decreased to 24 breaths per minute, suggesting some improvement in her work of breathing. However, despite this initial positive trend, her oxygen saturation remained suboptimal, hovering around 93%. The patient's anxiety persisted, and she continued to express feelings of chest discomfort. The healthcare team recognized the need for further intervention as her current status indicated only partial improvement.
To gain additional insights into her condition, a repeat arterial blood gas analysis was conducted. The results indicated a pH of 7.35, PaCO2 of 46 mmHg, and PaO2 of 72 mmHg. While these values showed slight improvements, they still pointed towards ongoing respiratory compromise. Additionally, a complete blood count revealed a mild leukocytosis, raising concerns about a possible infectious process contributing to her current state. Given these findings, the team decided to initiate a broad-spectrum antibiotic therapy to address a potential bacterial infection that might be exacerbating her asthma exacerbation.
While the CPAP continued to assist in ventilatory support, a decision was made to consult with a pulmonologist to evaluate the need for more aggressive interventions, such as bronchoscopy, to relieve any mucus plugging. The interprofessional team's collaborative approach and careful clinical reasoning aimed to prevent further complications and optimize her respiratory function. The patient's care plan was adjusted based on her evolving clinical picture, with a focus on continuous monitoring and readiness to escalate care if her condition warranted it.